Language Select
Varian Logo

Press Releases

October 25, 2017
Varian Medical Systems (NYSE: VAR) today announced it has been selected by Penn Medicine to install a Varian ProBeam® Compact single-room proton therapy system in a new cancer treatment center.... Read more
October 25, 2017
Fourth Quarter 2017 Summary Oncology gross orders grew 7% Booked 23 Halcyon™ orders, 50 orders since May launch GAAP net earnings per diluted share from continuing operations of $0.89 including... Read more
October 24, 2017
Varian (NYSE: VAR) today announced five patients with brain cancer became the first patients in the US to be treated using the company's HyperArc™ High Definition Radiotherapy (HDRT), a new type... Read more
October 23, 2017
A 71-year-old eye cancer patient has become the first person in the UK, and among the first in the world, to be treated using HyperArc™ high definition radiotherapy (HDRT) technology from Varian... Read more
October 17, 2017
Varian (NYSE: VAR) today announced an 80-year-old male with head & neck cancer became the first patient in Europe to be treated on the Halcyon™ system at University Hospitals Leuven (UZ Leuven)... Read more
October 02, 2017
Varian (NYSE: VAR), global leader in radiotherapy treatments systems and software, is announcing the publication of its annual Sustainability Report, detailing the company's policies and... Read more
September 21, 2017
Crawley, U.K. — September 21st, 2017 — Cancer patients in the U.K. will gain access to the country’s first Varian Halcyon™ radiotherapy treatment devices when the first of two systems are... Read more
September 21, 2017
Varian Medical Systems (NYSE: VAR) today announced a patient at Penn Medicine, with head & neck cancer, became the first person in the world to be treated on Varian's Halcyon™ system, its new... Read more
September 20, 2017
Varian Medical Systems (NYSE: VAR) today announced it has been ranked first in eight categories, including overall manufacturer performance, overall system performance and overall service... Read more
September 19, 2017
Varian Medical Systems (NYSE: VAR) today announced it will be demonstrating its new Halcyon™ platform for simplifying and enhancing virtually every aspect of image-guided volumetric intensity... Read more

Corporate Communications Contact

Mark Plungy
Director, Public Relations
650.424.5630
mark.plungy@varian.com

Investor Relations Contact

Mike Bruff
SVP, Investor Relations
650.424.5163
investors@varian.com

Monica Prokocki
Director, Investor Relations
650.424.5184
investors@varian.com